

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 6.88221900 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.88221900 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.88221900 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.88221900 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 6.88221900 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 6.88221900 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 6.79901508 |
| 8 | macrophage activation involved in immune response (GO:0002281) | 5.46014110 |
| 9 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 5.05062922 |
| 10 | positive regulation of interferon-alpha production (GO:0032727) | 4.95422991 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.81914110 |
| 12 | neutrophil activation involved in immune response (GO:0002283) | 4.77133840 |
| 13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.73509730 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.73509730 |
| 15 | regulation of interferon-alpha production (GO:0032647) | 4.69204983 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.60975082 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.56730722 |
| 18 | immunoglobulin mediated immune response (GO:0016064) | 4.52143465 |
| 19 | negative regulation of interleukin-12 production (GO:0032695) | 4.48807878 |
| 20 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.34445956 |
| 21 | response to host immune response (GO:0052572) | 4.34445956 |
| 22 | interferon-gamma production (GO:0032609) | 3.98940464 |
| 23 | detection of other organism (GO:0098543) | 3.98640225 |
| 24 | protein K11-linked deubiquitination (GO:0035871) | 3.96947311 |
| 25 | response to host (GO:0075136) | 3.96929816 |
| 26 | response to host defenses (GO:0052200) | 3.96929816 |
| 27 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.96929816 |
| 28 | respiratory burst (GO:0045730) | 3.96391304 |
| 29 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.85561590 |
| 30 | pinocytosis (GO:0006907) | 3.84539987 |
| 31 | mannose metabolic process (GO:0006013) | 3.81672194 |
| 32 | myeloid cell activation involved in immune response (GO:0002275) | 3.65195389 |
| 33 | activated T cell proliferation (GO:0050798) | 3.64997005 |
| 34 | detection of bacterium (GO:0016045) | 3.64845842 |
| 35 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.62229835 |
| 36 | positive regulation of antigen processing and presentation (GO:0002579) | 3.61136075 |
| 37 | neutrophil mediated immunity (GO:0002446) | 3.57893912 |
| 38 | macrophage activation (GO:0042116) | 3.53525594 |
| 39 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.51584713 |
| 40 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.51161576 |
| 41 | detection of molecule of bacterial origin (GO:0032490) | 3.49384131 |
| 42 | positive regulation of interferon-beta production (GO:0032728) | 3.48644621 |
| 43 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.47495703 |
| 44 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.44421493 |
| 45 | detection of external biotic stimulus (GO:0098581) | 3.41508217 |
| 46 | positive regulation of B cell differentiation (GO:0045579) | 3.40045765 |
| 47 | regulation of gamma-delta T cell activation (GO:0046643) | 3.39258210 |
| 48 | microglial cell activation (GO:0001774) | 3.39204797 |
| 49 | neutrophil activation (GO:0042119) | 3.37812297 |
| 50 | negative regulation of phagocytosis (GO:0050765) | 3.35625840 |
| 51 | negative regulation of interleukin-8 production (GO:0032717) | 3.35551982 |
| 52 | response to peptidoglycan (GO:0032494) | 3.32391228 |
| 53 | negative regulation of T cell mediated immunity (GO:0002710) | 3.31915268 |
| 54 | granulocyte activation (GO:0036230) | 3.26960133 |
| 55 | leukocyte degranulation (GO:0043299) | 3.26208035 |
| 56 | B cell receptor signaling pathway (GO:0050853) | 3.25465169 |
| 57 | positive regulation of mast cell activation (GO:0033005) | 3.25181374 |
| 58 | B cell mediated immunity (GO:0019724) | 3.24787500 |
| 59 | superoxide anion generation (GO:0042554) | 3.23611438 |
| 60 | natural killer cell mediated immunity (GO:0002228) | 3.20033622 |
| 61 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.20033622 |
| 62 | I-kappaB phosphorylation (GO:0007252) | 3.18033551 |
| 63 | melanin biosynthetic process (GO:0042438) | 3.17641631 |
| 64 | cellular extravasation (GO:0045123) | 3.14078331 |
| 65 | regulation of regulatory T cell differentiation (GO:0045589) | 3.13656509 |
| 66 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.11637194 |
| 67 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.10447323 |
| 68 | leukocyte aggregation (GO:0070486) | 3.10429614 |
| 69 | detection of biotic stimulus (GO:0009595) | 3.07482473 |
| 70 | regulation of antigen processing and presentation (GO:0002577) | 3.03489755 |
| 71 | tolerance induction (GO:0002507) | 3.00709069 |
| 72 | regulation of mast cell degranulation (GO:0043304) | 3.00059959 |
| 73 | negative regulation of mast cell activation (GO:0033004) | 2.99205871 |
| 74 | melanin metabolic process (GO:0006582) | 2.96011241 |
| 75 | response to muramyl dipeptide (GO:0032495) | 2.95322911 |
| 76 | regulation of mast cell activation (GO:0033003) | 2.93223213 |
| 77 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.93039452 |
| 78 | negative regulation of interleukin-1 production (GO:0032692) | 2.92549945 |
| 79 | positive regulation of mast cell degranulation (GO:0043306) | 2.92235403 |
| 80 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.92235403 |
| 81 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.90207289 |
| 82 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.89788385 |
| 83 | regulation of B cell differentiation (GO:0045577) | 2.87271118 |
| 84 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.87229180 |
| 85 | apoptotic cell clearance (GO:0043277) | 2.86983742 |
| 86 | regulation of T cell tolerance induction (GO:0002664) | 2.86975679 |
| 87 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.86273529 |
| 88 | natural killer cell activation involved in immune response (GO:0002323) | 2.85998732 |
| 89 | keratan sulfate catabolic process (GO:0042340) | 2.85627255 |
| 90 | regulation of tolerance induction (GO:0002643) | 2.84824926 |
| 91 | regulation of leukocyte degranulation (GO:0043300) | 2.84598172 |
| 92 | dendritic cell migration (GO:0036336) | 2.82685265 |
| 93 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.82611174 |
| 94 | negative regulation of granulocyte differentiation (GO:0030853) | 2.81183204 |
| 95 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.80448165 |
| 96 | actin nucleation (GO:0045010) | 2.80257090 |
| 97 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.79530128 |
| 98 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.79500283 |
| 99 | response to type I interferon (GO:0034340) | 2.79073709 |
| 100 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.78907837 |
| 101 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.78426965 |
| 102 | type I interferon signaling pathway (GO:0060337) | 2.77770814 |
| 103 | cellular response to type I interferon (GO:0071357) | 2.77770814 |
| 104 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.77709610 |
| 105 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.77709610 |
| 106 | regulation of phagocytosis (GO:0050764) | 2.74655453 |
| 107 | negative regulation of interleukin-17 production (GO:0032700) | 2.73271341 |
| 108 | negative regulation of B cell proliferation (GO:0030889) | 2.73233913 |
| 109 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.72863598 |
| 110 | regulation of memory T cell differentiation (GO:0043380) | 2.72747116 |
| 111 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.72231317 |
| 112 | response to fungus (GO:0009620) | 2.72040019 |
| 113 | leukocyte mediated cytotoxicity (GO:0001909) | 2.71893783 |
| 114 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.71843439 |
| 115 | myeloid leukocyte activation (GO:0002274) | 2.71660983 |
| 116 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.70727679 |
| 117 | negative regulation of cell killing (GO:0031342) | 2.70727679 |
| 118 | defense response to protozoan (GO:0042832) | 2.69291163 |
| 119 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.68836967 |
| 120 | response to protozoan (GO:0001562) | 2.68458196 |
| 121 | negative regulation of interleukin-6 production (GO:0032715) | 2.68021663 |
| 122 | mast cell activation (GO:0045576) | 2.66988342 |
| 123 | response to interleukin-15 (GO:0070672) | 2.66846015 |
| 124 | regulation of interferon-beta production (GO:0032648) | 2.66728349 |
| 125 | regulation of mononuclear cell migration (GO:0071675) | 2.66612118 |
| 126 | myeloid leukocyte mediated immunity (GO:0002444) | 2.66608723 |
| 127 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.66121136 |
| 128 | germinal center formation (GO:0002467) | 2.65960310 |
| 129 | neutrophil chemotaxis (GO:0030593) | 2.65192262 |
| 130 | positive regulation of leukocyte degranulation (GO:0043302) | 2.64086518 |
| 131 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.63882197 |
| 132 | reactive oxygen species biosynthetic process (GO:1903409) | 2.62977565 |
| 133 | myeloid dendritic cell activation (GO:0001773) | 2.60282305 |
| 134 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.60060431 |
| 135 | regulation of cholesterol storage (GO:0010885) | 2.58179435 |
| 136 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.57009540 |
| 137 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.56847557 |
| 138 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.56519275 |
| 139 | regulation of apoptotic cell clearance (GO:2000425) | 2.55442040 |
| 140 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.54873601 |
| 141 | cytidine deamination (GO:0009972) | 2.54847711 |
| 142 | cytidine metabolic process (GO:0046087) | 2.54847711 |
| 143 | cytidine catabolic process (GO:0006216) | 2.54847711 |
| 144 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.54750207 |
| 145 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.54420823 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.89191858 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.46029432 |
| 3 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.12837905 |
| 4 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.92548040 |
| 5 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.63858837 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.39319556 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.38915260 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.25162576 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.24244887 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.11341299 |
| 11 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.02242353 |
| 12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.01232864 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.87078809 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.83134925 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.76914792 |
| 16 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.73589682 |
| 17 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.60234260 |
| 18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.59838704 |
| 19 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.50846751 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.50330270 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.40671937 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.22994200 |
| 23 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.21768302 |
| 24 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.20379189 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.05492225 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.00555129 |
| 27 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.00421471 |
| 28 | SPI1_23127762_ChIP-Seq_K562_Human | 2.00326846 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.98469886 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.94171556 |
| 31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.90550757 |
| 32 | MYC_22102868_ChIP-Seq_BL_Human | 1.88555896 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.87623175 |
| 34 | MYB_26560356_Chip-Seq_TH2_Human | 1.86946715 |
| 35 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.83044925 |
| 36 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.80724961 |
| 37 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.77633766 |
| 38 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.74657537 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.72123325 |
| 40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69215858 |
| 41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.68088552 |
| 42 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.66847367 |
| 43 | MYB_26560356_Chip-Seq_TH1_Human | 1.65418691 |
| 44 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.62127493 |
| 45 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.59913721 |
| 46 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.56827399 |
| 47 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.56714603 |
| 48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.50828553 |
| 49 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47788829 |
| 50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44609045 |
| 51 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.43149506 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.40795577 |
| 53 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40650725 |
| 54 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.38735415 |
| 55 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.36179573 |
| 56 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.35215015 |
| 57 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.34995182 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.32171524 |
| 59 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.28921944 |
| 60 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28908104 |
| 61 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28488167 |
| 62 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25582091 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25102719 |
| 64 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23297239 |
| 65 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23265707 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23148913 |
| 67 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.22241328 |
| 68 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22011707 |
| 69 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.21452966 |
| 70 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.21408181 |
| 71 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.20186175 |
| 72 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.20153303 |
| 73 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19984347 |
| 74 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19849159 |
| 75 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.18739621 |
| 76 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18011908 |
| 77 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.17155975 |
| 78 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.16244182 |
| 79 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15417483 |
| 80 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.15022350 |
| 81 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.15018450 |
| 82 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12945262 |
| 83 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.12167237 |
| 84 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.11576312 |
| 85 | GATA3_26560356_Chip-Seq_TH2_Human | 1.09288809 |
| 86 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09268583 |
| 87 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.09202076 |
| 88 | VDR_22108803_ChIP-Seq_LS180_Human | 1.08927573 |
| 89 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08812472 |
| 90 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07984729 |
| 91 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.05619760 |
| 92 | MAF_26560356_Chip-Seq_TH2_Human | 1.05037667 |
| 93 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.04658364 |
| 94 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04629116 |
| 95 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.04384322 |
| 96 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.04372895 |
| 97 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.03001464 |
| 98 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01161225 |
| 99 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00403969 |
| 100 | TP53_16413492_ChIP-PET_HCT116_Human | 1.00237418 |
| 101 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.99591138 |
| 102 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.98122471 |
| 103 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.97958126 |
| 104 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.97836995 |
| 105 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.97469396 |
| 106 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.95447995 |
| 107 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94719293 |
| 108 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94484304 |
| 109 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.93028907 |
| 110 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.92210452 |
| 111 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.90272163 |
| 112 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89877029 |
| 113 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.89768486 |
| 114 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.89713948 |
| 115 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.89346751 |
| 116 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.89233365 |
| 117 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.89135976 |
| 118 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88275325 |
| 119 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.88135027 |
| 120 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.87254104 |
| 121 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.87199347 |
| 122 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.87185185 |
| 123 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87169926 |
| 124 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.86117054 |
| 125 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.85699431 |
| 126 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.84477339 |
| 127 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84258313 |
| 128 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.83744045 |
| 129 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.83654811 |
| 130 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.83395558 |
| 131 | GATA3_26560356_Chip-Seq_TH1_Human | 0.82260343 |
| 132 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82056002 |
| 133 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81984501 |
| 134 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.81842793 |
| 135 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.81649021 |
| 136 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.80974304 |
| 137 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.80799695 |
| 138 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80436538 |
| 139 | AR_25329375_ChIP-Seq_VCAP_Human | 0.80339669 |
| 140 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.79929466 |
| 141 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78988171 |
| 142 | GATA2_19941826_ChIP-Seq_K562_Human | 0.78783619 |
| 143 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78617264 |
| 144 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78528753 |
| 145 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.78522359 |
| 146 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.77489450 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.47584903 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.83549643 |
| 3 | MP0003303_peritoneal_inflammation | 3.42339691 |
| 4 | MP0003436_decreased_susceptibility_to | 2.97856199 |
| 5 | MP0003172_abnormal_lysosome_physiology | 2.84366875 |
| 6 | MP0009840_abnormal_foam_cell | 2.75519373 |
| 7 | MP0002419_abnormal_innate_immunity | 2.74322705 |
| 8 | MP0000569_abnormal_digit_pigmentation | 2.69888552 |
| 9 | MP0005387_immune_system_phenotype | 2.60578521 |
| 10 | MP0001790_abnormal_immune_system | 2.60578521 |
| 11 | MP0001800_abnormal_humoral_immune | 2.44495102 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.42643825 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.42059382 |
| 14 | MP0006082_CNS_inflammation | 2.41503822 |
| 15 | MP0000685_abnormal_immune_system | 2.40263430 |
| 16 | MP0005025_abnormal_response_to | 2.25586688 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.21101216 |
| 18 | MP0008438_abnormal_cutaneous_collagen | 2.10124589 |
| 19 | MP0005464_abnormal_platelet_physiology | 2.08600847 |
| 20 | MP0002723_abnormal_immune_serum | 2.07704378 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.05133658 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.02722580 |
| 23 | MP0005257_abnormal_intraocular_pressure | 2.00479688 |
| 24 | MP0009785_altered_susceptibility_to | 1.98822309 |
| 25 | MP0002420_abnormal_adaptive_immunity | 1.96987802 |
| 26 | MP0001819_abnormal_immune_cell | 1.96643399 |
| 27 | MP0004510_myositis | 1.93054074 |
| 28 | MP0000604_amyloidosis | 1.89008754 |
| 29 | MP0005167_abnormal_blood-brain_barrier | 1.88426682 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.84300890 |
| 31 | MP0010307_abnormal_tumor_latency | 1.82421096 |
| 32 | MP0004947_skin_inflammation | 1.76394998 |
| 33 | MP0000372_irregular_coat_pigmentation | 1.73711641 |
| 34 | MP0005174_abnormal_tail_pigmentation | 1.72688290 |
| 35 | MP0005671_abnormal_response_to | 1.71329327 |
| 36 | MP0003705_abnormal_hypodermis_morpholog | 1.69478454 |
| 37 | MP0001533_abnormal_skeleton_physiology | 1.64379667 |
| 38 | MP0003828_pulmonary_edema | 1.63316513 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.59824696 |
| 40 | MP0000371_diluted_coat_color | 1.59223949 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.58491914 |
| 42 | MP0003763_abnormal_thymus_physiology | 1.58180114 |
| 43 | MP0000716_abnormal_immune_system | 1.53505109 |
| 44 | MP0003448_altered_tumor_morphology | 1.52461041 |
| 45 | MP0002405_respiratory_system_inflammati | 1.52038555 |
| 46 | MP0005310_abnormal_salivary_gland | 1.51585127 |
| 47 | MP0003566_abnormal_cell_adhesion | 1.51564049 |
| 48 | MP0000689_abnormal_spleen_morphology | 1.49399193 |
| 49 | MP0008004_abnormal_stomach_pH | 1.49065033 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.48591024 |
| 51 | MP0002398_abnormal_bone_marrow | 1.47732655 |
| 52 | MP0003806_abnormal_nucleotide_metabolis | 1.46956103 |
| 53 | MP0003183_abnormal_peptide_metabolism | 1.42804989 |
| 54 | MP0002277_abnormal_respiratory_mucosa | 1.42033513 |
| 55 | MP0000015_abnormal_ear_pigmentation | 1.41360161 |
| 56 | MP0000858_altered_metastatic_potential | 1.40491934 |
| 57 | MP0005084_abnormal_gallbladder_morpholo | 1.37481579 |
| 58 | MP0010155_abnormal_intestine_physiology | 1.33702121 |
| 59 | MP0008469_abnormal_protein_level | 1.33022430 |
| 60 | MP0000343_altered_response_to | 1.32923938 |
| 61 | MP0005408_hypopigmentation | 1.31793279 |
| 62 | MP0006054_spinal_hemorrhage | 1.30467829 |
| 63 | MP0003724_increased_susceptibility_to | 1.29041303 |
| 64 | * MP0002429_abnormal_blood_cell | 1.27951032 |
| 65 | MP0002722_abnormal_immune_system | 1.27879045 |
| 66 | MP0003690_abnormal_glial_cell | 1.26726933 |
| 67 | MP0001853_heart_inflammation | 1.21959939 |
| 68 | MP0002998_abnormal_bone_remodeling | 1.19189629 |
| 69 | MP0001958_emphysema | 1.18768884 |
| 70 | MP0002006_tumorigenesis | 1.13565112 |
| 71 | MP0009333_abnormal_splenocyte_physiolog | 1.12898898 |
| 72 | MP0002933_joint_inflammation | 1.12787266 |
| 73 | MP0002877_abnormal_melanocyte_morpholog | 1.11713308 |
| 74 | MP0004883_abnormal_blood_vessel | 1.10850827 |
| 75 | MP0001851_eye_inflammation | 1.09204471 |
| 76 | MP0003866_abnormal_defecation | 1.08763985 |
| 77 | MP0003195_calcinosis | 1.07510618 |
| 78 | MP0009278_abnormal_bone_marrow | 1.05044919 |
| 79 | MP0002396_abnormal_hematopoietic_system | 1.04745548 |
| 80 | MP0009764_decreased_sensitivity_to | 0.99824511 |
| 81 | MP0004808_abnormal_hematopoietic_stem | 0.99436675 |
| 82 | MP0010352_gastrointestinal_tract_polyps | 0.99138485 |
| 83 | MP0004381_abnormal_hair_follicle | 0.98046672 |
| 84 | MP0001663_abnormal_digestive_system | 0.97712049 |
| 85 | MP0003045_fibrosis | 0.97579088 |
| 86 | MP0002254_reproductive_system_inflammat | 0.96320239 |
| 87 | MP0005166_decreased_susceptibility_to | 0.94314465 |
| 88 | MP0003075_altered_response_to | 0.94246904 |
| 89 | MP0003656_abnormal_erythrocyte_physiolo | 0.93725673 |
| 90 | MP0001873_stomach_inflammation | 0.90861519 |
| 91 | MP0005397_hematopoietic_system_phenotyp | 0.89906920 |
| 92 | MP0001545_abnormal_hematopoietic_system | 0.89906920 |
| 93 | MP0005164_abnormal_response_to | 0.89770359 |
| 94 | MP0005075_abnormal_melanosome_morpholog | 0.89571751 |
| 95 | MP0001986_abnormal_taste_sensitivity | 0.88351483 |
| 96 | MP0000490_abnormal_crypts_of | 0.87803479 |
| 97 | MP0002095_abnormal_skin_pigmentation | 0.87296366 |
| 98 | MP0000249_abnormal_blood_vessel | 0.86323197 |
| 99 | MP0005171_absent_coat_pigmentation | 0.83257960 |
| 100 | MP0005023_abnormal_wound_healing | 0.82492975 |
| 101 | MP0005451_abnormal_body_composition | 0.81626619 |
| 102 | MP0001919_abnormal_reproductive_system | 0.80109385 |
| 103 | MP0002132_abnormal_respiratory_system | 0.79986888 |
| 104 | MP0000609_abnormal_liver_physiology | 0.78763510 |
| 105 | MP0003091_abnormal_cell_migration | 0.78617360 |
| 106 | MP0008875_abnormal_xenobiotic_pharmacok | 0.78312447 |
| 107 | MP0005390_skeleton_phenotype | 0.77469661 |
| 108 | MP0004484_altered_response_of | 0.76745383 |
| 109 | MP0002332_abnormal_exercise_endurance | 0.76542128 |
| 110 | MP0000767_abnormal_smooth_muscle | 0.75442890 |
| 111 | MP0002928_abnormal_bile_duct | 0.74733826 |
| 112 | MP0005076_abnormal_cell_differentiation | 0.74154751 |
| 113 | MP0008260_abnormal_autophagy | 0.73308956 |
| 114 | MP0009763_increased_sensitivity_to | 0.73256724 |
| 115 | MP0003795_abnormal_bone_structure | 0.71330197 |
| 116 | MP0009765_abnormal_xenobiotic_induced | 0.71235209 |
| 117 | MP0000703_abnormal_thymus_morphology | 0.71213455 |
| 118 | MP0000230_abnormal_systemic_arterial | 0.70992404 |
| 119 | MP0002136_abnormal_kidney_physiology | 0.70834136 |
| 120 | MP0004185_abnormal_adipocyte_glucose | 0.70449228 |
| 121 | MP0001915_intracranial_hemorrhage | 0.67242726 |
| 122 | MP0003453_abnormal_keratinocyte_physiol | 0.67056237 |
| 123 | MP0005197_abnormal_uvea_morphology | 0.67051042 |
| 124 | MP0000598_abnormal_liver_morphology | 0.66978177 |
| 125 | MP0002090_abnormal_vision | 0.66539423 |
| 126 | MP0003252_abnormal_bile_duct | 0.64309906 |
| 127 | MP0005647_abnormal_sex_gland | 0.64108650 |
| 128 | MP0005410_abnormal_fertilization | 0.64048082 |
| 129 | MP0001501_abnormal_sleep_pattern | 0.62463655 |
| 130 | MP0002693_abnormal_pancreas_physiology | 0.62385888 |
| 131 | MP0003646_muscle_fatigue | 0.61894192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 5.64934785 |
| 2 | Increased cerebral lipofuscin (HP:0011813) | 5.59622359 |
| 3 | Vacuolated lymphocytes (HP:0001922) | 5.51550649 |
| 4 | Recurrent abscess formation (HP:0002722) | 5.35309209 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 5.21893488 |
| 6 | Dysostosis multiplex (HP:0000943) | 4.91258497 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 4.87018601 |
| 8 | Eczematoid dermatitis (HP:0000976) | 4.84044221 |
| 9 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.46660782 |
| 10 | Mucopolysacchariduria (HP:0008155) | 4.42575356 |
| 11 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.42575356 |
| 12 | Keratoconjunctivitis (HP:0001096) | 4.33331635 |
| 13 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.27496069 |
| 14 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.27496069 |
| 15 | Abnormality of glycolipid metabolism (HP:0010969) | 4.27496069 |
| 16 | Keratoconjunctivitis sicca (HP:0001097) | 4.22961495 |
| 17 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.20518647 |
| 18 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.20518647 |
| 19 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.20518647 |
| 20 | Abnormality of macrophages (HP:0004311) | 4.16568304 |
| 21 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.02559948 |
| 22 | Prolonged bleeding time (HP:0003010) | 3.97454862 |
| 23 | Disinhibition (HP:0000734) | 3.80606057 |
| 24 | Loss of speech (HP:0002371) | 3.69501200 |
| 25 | Encephalitis (HP:0002383) | 3.51276017 |
| 26 | Hemoptysis (HP:0002105) | 3.46631727 |
| 27 | Autoimmune thrombocytopenia (HP:0001973) | 3.28107191 |
| 28 | Myositis (HP:0100614) | 3.15941299 |
| 29 | Asymmetric septal hypertrophy (HP:0001670) | 3.12948369 |
| 30 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.10279860 |
| 31 | Gangrene (HP:0100758) | 3.10058831 |
| 32 | Epistaxis (HP:0000421) | 3.08380636 |
| 33 | Recurrent skin infections (HP:0001581) | 3.06771661 |
| 34 | Glomerulonephritis (HP:0000099) | 3.00665471 |
| 35 | T lymphocytopenia (HP:0005403) | 2.97374798 |
| 36 | Axonal loss (HP:0003447) | 2.97343685 |
| 37 | Abnormality of T cell number (HP:0011839) | 2.96952727 |
| 38 | Gastrointestinal infarctions (HP:0005244) | 2.91972480 |
| 39 | Spontaneous hematomas (HP:0007420) | 2.91283626 |
| 40 | Mediastinal lymphadenopathy (HP:0100721) | 2.90625304 |
| 41 | Episodic fever (HP:0001954) | 2.86246827 |
| 42 | Spondylolisthesis (HP:0003302) | 2.83067467 |
| 43 | Cellulitis (HP:0100658) | 2.79241344 |
| 44 | Recurrent viral infections (HP:0004429) | 2.78844608 |
| 45 | Recurrent fungal infections (HP:0002841) | 2.78009531 |
| 46 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.77165717 |
| 47 | Anorexia (HP:0002039) | 2.74988321 |
| 48 | Gingivitis (HP:0000230) | 2.74657768 |
| 49 | Obstructive lung disease (HP:0006536) | 2.74022993 |
| 50 | Chronic obstructive pulmonary disease (HP:0006510) | 2.74022993 |
| 51 | Pulmonary embolism (HP:0002204) | 2.69324990 |
| 52 | Abnormality of T cells (HP:0002843) | 2.67244068 |
| 53 | Leukocytosis (HP:0001974) | 2.66444465 |
| 54 | Chronic otitis media (HP:0000389) | 2.64687654 |
| 55 | Myocardial infarction (HP:0001658) | 2.61197072 |
| 56 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.60722216 |
| 57 | Orchitis (HP:0100796) | 2.58763326 |
| 58 | Colitis (HP:0002583) | 2.58582282 |
| 59 | Chest pain (HP:0100749) | 2.57314149 |
| 60 | Osteomyelitis (HP:0002754) | 2.53522109 |
| 61 | Alveolar cell carcinoma (HP:0006519) | 2.52397805 |
| 62 | Agnosia (HP:0010524) | 2.48239586 |
| 63 | Periodontitis (HP:0000704) | 2.48193467 |
| 64 | Thoracic kyphosis (HP:0002942) | 2.47242152 |
| 65 | Abnormality of T cell physiology (HP:0011840) | 2.46949610 |
| 66 | Pustule (HP:0200039) | 2.46572568 |
| 67 | Abnormality of the pericardium (HP:0001697) | 2.46520455 |
| 68 | Hematochezia (HP:0002573) | 2.44924094 |
| 69 | Diminished motivation (HP:0000745) | 2.40782465 |
| 70 | Inflammation of the large intestine (HP:0002037) | 2.40632265 |
| 71 | Keratitis (HP:0000491) | 2.40418252 |
| 72 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.39594899 |
| 73 | Interstitial pulmonary disease (HP:0006530) | 2.39361294 |
| 74 | J-shaped sella turcica (HP:0002680) | 2.38942013 |
| 75 | Abnormal platelet volume (HP:0011876) | 2.37521067 |
| 76 | Vertigo (HP:0002321) | 2.36996616 |
| 77 | Vasculitis (HP:0002633) | 2.36243423 |
| 78 | Osteolytic defects of the hand bones (HP:0009699) | 2.34475981 |
| 79 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.34475981 |
| 80 | Increased IgM level (HP:0003496) | 2.33757953 |
| 81 | Petechiae (HP:0000967) | 2.33197247 |
| 82 | Meningitis (HP:0001287) | 2.33128272 |
| 83 | Abnormality of the lumbar spine (HP:0100712) | 2.31542030 |
| 84 | Apathy (HP:0000741) | 2.30561578 |
| 85 | Gastrointestinal inflammation (HP:0004386) | 2.30374627 |
| 86 | Recurrent bronchitis (HP:0002837) | 2.29581730 |
| 87 | Abnormality of the pleura (HP:0002103) | 2.29338201 |
| 88 | Polyneuropathy (HP:0001271) | 2.27944892 |
| 89 | Nasal polyposis (HP:0100582) | 2.27289643 |
| 90 | Gingival bleeding (HP:0000225) | 2.24077627 |
| 91 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.23552852 |
| 92 | Increased IgE level (HP:0003212) | 2.22165350 |
| 93 | Complement deficiency (HP:0004431) | 2.21933428 |
| 94 | Abnormality of complement system (HP:0005339) | 2.21641930 |
| 95 | IgM deficiency (HP:0002850) | 2.19222854 |
| 96 | Emphysema (HP:0002097) | 2.19183377 |
| 97 | Autoimmune hemolytic anemia (HP:0001890) | 2.16707367 |
| 98 | Nephritis (HP:0000123) | 2.16394290 |
| 99 | Ovoid vertebral bodies (HP:0003300) | 2.16051637 |
| 100 | Basal ganglia calcification (HP:0002135) | 2.15526053 |
| 101 | Cerebral aneurysm (HP:0004944) | 2.12504340 |
| 102 | Menorrhagia (HP:0000132) | 2.11669572 |
| 103 | Abnormality of the nasal mucosa (HP:0000433) | 2.11269267 |
| 104 | Gastrointestinal stroma tumor (HP:0100723) | 2.08977082 |
| 105 | Urticaria (HP:0001025) | 2.08632487 |
| 106 | Hepatosplenomegaly (HP:0001433) | 2.06619444 |
| 107 | Congenital sensorineural hearing impairment (HP:0008527) | 2.06586367 |
| 108 | Increased serum ferritin (HP:0003281) | 2.06414637 |
| 109 | Retrobulbar optic neuritis (HP:0100654) | 2.06026671 |
| 110 | Optic neuritis (HP:0100653) | 2.06026671 |
| 111 | Recurrent cutaneous fungal infections (HP:0011370) | 2.05957311 |
| 112 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.05957311 |
| 113 | Abnormality of iron homeostasis (HP:0011031) | 2.04765067 |
| 114 | Abolished electroretinogram (ERG) (HP:0000550) | 2.04410254 |
| 115 | Cervical subluxation (HP:0003308) | 2.03485942 |
| 116 | Eosinophilia (HP:0001880) | 2.03263535 |
| 117 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.03122009 |
| 118 | Glomerulopathy (HP:0100820) | 2.02252495 |
| 119 | Amyloidosis (HP:0011034) | 2.02057696 |
| 120 | Recurrent pneumonia (HP:0006532) | 2.01298317 |
| 121 | Upper motor neuron abnormality (HP:0002127) | 1.99746400 |
| 122 | Increased mean platelet volume (HP:0011877) | 1.99523681 |
| 123 | Congenital stationary night blindness (HP:0007642) | 1.99030914 |
| 124 | Abnormality of the thoracic spine (HP:0100711) | 1.98980340 |
| 125 | Conjunctival telangiectasia (HP:0000524) | 1.98655778 |
| 126 | Global brain atrophy (HP:0002283) | 1.98163606 |
| 127 | Albinism (HP:0001022) | 1.96484354 |
| 128 | Cheilitis (HP:0100825) | 1.95233667 |
| 129 | Abnormality of eosinophils (HP:0001879) | 1.94931415 |
| 130 | Arterial thrombosis (HP:0004420) | 1.94258018 |
| 131 | Pulmonary infiltrates (HP:0002113) | 1.93990931 |
| 132 | Joint hemorrhage (HP:0005261) | 1.93922049 |
| 133 | Progressive neurologic deterioration (HP:0002344) | 1.93687752 |
| 134 | Joint stiffness (HP:0001387) | 1.93252687 |
| 135 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.92980120 |
| 136 | Increased CSF protein (HP:0002922) | 1.92910580 |
| 137 | Recurrent lower respiratory tract infections (HP:0002783) | 1.92532220 |
| 138 | Purpura (HP:0000979) | 1.92231415 |
| 139 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.89219964 |
| 140 | Neuronal loss in central nervous system (HP:0002529) | 1.88887728 |
| 141 | Pathologic fracture (HP:0002756) | 1.88087404 |
| 142 | Ocular albinism (HP:0001107) | 1.87870061 |
| 143 | Acne (HP:0001061) | 1.86164736 |
| 144 | Peripheral demyelination (HP:0011096) | 1.85865109 |
| 145 | IgG deficiency (HP:0004315) | 1.84215325 |
| 146 | Granulocytopenia (HP:0001913) | 1.82026323 |
| 147 | Abnormality of the endocardium (HP:0004306) | 1.81905592 |
| 148 | Inappropriate behavior (HP:0000719) | 1.80940255 |
| 149 | Agitation (HP:0000713) | 1.80733388 |
| 150 | Tinnitus (HP:0000360) | 1.76217138 |
| 151 | Attenuation of retinal blood vessels (HP:0007843) | 1.76024888 |
| 152 | Thick nail (HP:0001805) | 1.75178474 |
| 153 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.73865004 |
| 154 | Abnormal platelet function (HP:0011869) | 1.73309333 |
| 155 | Impaired platelet aggregation (HP:0003540) | 1.73309333 |
| 156 | Hypergammaglobulinemia (HP:0010702) | 1.72045003 |
| 157 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.70798921 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.32645324 |
| 2 | FRK | 4.16707219 |
| 3 | BLK | 3.85859019 |
| 4 | ERN1 | 3.66333318 |
| 5 | MAP4K1 | 3.33220220 |
| 6 | KIT | 3.08276804 |
| 7 | TYK2 | 2.94088696 |
| 8 | TRIB3 | 2.92294214 |
| 9 | TAOK3 | 2.72262013 |
| 10 | TBK1 | 2.55842566 |
| 11 | RIPK4 | 2.51382350 |
| 12 | PKN2 | 2.35488525 |
| 13 | IRAK4 | 2.20699198 |
| 14 | MST1R | 2.19921704 |
| 15 | TGFBR2 | 2.10254178 |
| 16 | STK24 | 1.93437398 |
| 17 | CSF1R | 1.88903818 |
| 18 | ADRBK2 | 1.87500400 |
| 19 | SCYL2 | 1.76866413 |
| 20 | MAP3K13 | 1.71650991 |
| 21 | IRAK1 | 1.70097112 |
| 22 | MAP3K14 | 1.68593906 |
| 23 | LRRK2 | 1.68541516 |
| 24 | STK10 | 1.65771733 |
| 25 | ZAP70 | 1.63630928 |
| 26 | MAP2K3 | 1.63629122 |
| 27 | ACVR1B | 1.63407233 |
| 28 | JAK1 | 1.61995118 |
| 29 | JAK3 | 1.60043010 |
| 30 | SYK | 1.55438554 |
| 31 | TNK2 | 1.53485061 |
| 32 | GRK6 | 1.48928724 |
| 33 | IRAK3 | 1.48407468 |
| 34 | IKBKE | 1.45241599 |
| 35 | TIE1 | 1.42916406 |
| 36 | FES | 1.39509845 |
| 37 | EPHB1 | 1.38835358 |
| 38 | WNK3 | 1.37741421 |
| 39 | TTN | 1.36281416 |
| 40 | BTK | 1.35838224 |
| 41 | IKBKB | 1.34926623 |
| 42 | HCK | 1.30126155 |
| 43 | RIPK1 | 1.28799647 |
| 44 | PTK6 | 1.28141899 |
| 45 | GRK7 | 1.26437463 |
| 46 | NEK9 | 1.25618856 |
| 47 | BMX | 1.25269459 |
| 48 | PTK2B | 1.22744400 |
| 49 | RPS6KA4 | 1.16498559 |
| 50 | CSK | 1.16034619 |
| 51 | CAMK1D | 1.13580867 |
| 52 | MAP3K10 | 1.13329218 |
| 53 | ITK | 1.11094151 |
| 54 | PAK4 | 1.08518367 |
| 55 | TAOK1 | 1.06842977 |
| 56 | LYN | 1.06252532 |
| 57 | FGFR4 | 1.05409097 |
| 58 | YES1 | 1.04070053 |
| 59 | MARK3 | 1.03425116 |
| 60 | TEC | 0.99927618 |
| 61 | FLT3 | 0.99831238 |
| 62 | BMPR2 | 0.97430546 |
| 63 | EEF2K | 0.97329279 |
| 64 | JAK2 | 0.92952115 |
| 65 | LCK | 0.92562953 |
| 66 | CLK1 | 0.87290226 |
| 67 | EPHA3 | 0.86843928 |
| 68 | CDK6 | 0.86420401 |
| 69 | FGFR3 | 0.85047711 |
| 70 | SIK3 | 0.83428491 |
| 71 | DAPK2 | 0.83246302 |
| 72 | PINK1 | 0.81871686 |
| 73 | STK38L | 0.78071909 |
| 74 | MAP3K3 | 0.75532160 |
| 75 | FGR | 0.74310796 |
| 76 | FER | 0.72437756 |
| 77 | PIM1 | 0.71645362 |
| 78 | MST4 | 0.70482387 |
| 79 | NME2 | 0.69968204 |
| 80 | CAMK1G | 0.69721381 |
| 81 | TRPM7 | 0.69365942 |
| 82 | CHUK | 0.68588608 |
| 83 | PIM2 | 0.67261867 |
| 84 | ADRBK1 | 0.65803341 |
| 85 | DMPK | 0.65225054 |
| 86 | MAP3K8 | 0.65196241 |
| 87 | IRAK2 | 0.64127529 |
| 88 | MAP2K6 | 0.63630283 |
| 89 | GRK1 | 0.60581000 |
| 90 | MATK | 0.59802863 |
| 91 | ABL1 | 0.58666848 |
| 92 | EGFR | 0.58391125 |
| 93 | STK3 | 0.58072368 |
| 94 | STK4 | 0.57172767 |
| 95 | NUAK1 | 0.52839582 |
| 96 | BMPR1B | 0.52434501 |
| 97 | ZAK | 0.51657569 |
| 98 | KSR2 | 0.50932878 |
| 99 | MAP3K11 | 0.48975122 |
| 100 | MOS | 0.48513069 |
| 101 | NLK | 0.47879049 |
| 102 | SIK2 | 0.47777651 |
| 103 | CDK4 | 0.47700959 |
| 104 | PDPK1 | 0.46803012 |
| 105 | NEK2 | 0.46423658 |
| 106 | PRKCD | 0.46165317 |
| 107 | CAMKK1 | 0.45986591 |
| 108 | ABL2 | 0.45701725 |
| 109 | PDK1 | 0.45114427 |
| 110 | CDK12 | 0.44560867 |
| 111 | MAP3K5 | 0.44357385 |
| 112 | CAMKK2 | 0.43727929 |
| 113 | TESK2 | 0.43533588 |
| 114 | MAP3K2 | 0.42741249 |
| 115 | PRKCZ | 0.42538141 |
| 116 | TRIM28 | 0.41256708 |
| 117 | MET | 0.39232236 |
| 118 | GSK3A | 0.38771919 |
| 119 | PIK3CG | 0.38517742 |
| 120 | PRKG2 | 0.38382094 |
| 121 | TESK1 | 0.37046386 |
| 122 | MAPKAPK2 | 0.36647678 |
| 123 | CDK9 | 0.36064900 |
| 124 | PRKCH | 0.35192191 |
| 125 | OXSR1 | 0.34890204 |
| 126 | PRKD2 | 0.34243695 |
| 127 | HIPK2 | 0.33973958 |
| 128 | FYN | 0.33785314 |
| 129 | IGF1R | 0.33775017 |
| 130 | MAP3K6 | 0.33700740 |
| 131 | MAPK11 | 0.33699235 |
| 132 | MAP3K1 | 0.33184500 |
| 133 | TAOK2 | 0.33182460 |
| 134 | TGFBR1 | 0.32006143 |
| 135 | PRKCQ | 0.31539798 |
| 136 | MAPK7 | 0.31276830 |
| 137 | RET | 0.29363145 |
| 138 | GRK5 | 0.28841209 |
| 139 | MAPK12 | 0.28333294 |
| 140 | CDC42BPA | 0.27981860 |
| 141 | MAPKAPK3 | 0.27424220 |
| 142 | PRKAA2 | 0.27091093 |
| 143 | INSRR | 0.26495366 |
| 144 | TLK1 | 0.24639726 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.83138943 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 3.56001154 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.43615027 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 3.20647537 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.83543787 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.58823082 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.38774117 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.31742420 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.16758831 |
| 10 | Pertussis_Homo sapiens_hsa05133 | 2.14349552 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 2.13928276 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.10748748 |
| 13 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.08484276 |
| 14 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.95085340 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.88092622 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.86022082 |
| 17 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.75658832 |
| 18 | Phagosome_Homo sapiens_hsa04145 | 1.73796154 |
| 19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.72921855 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.61915627 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.60950544 |
| 22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.60434814 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.55050225 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53321693 |
| 25 | Apoptosis_Homo sapiens_hsa04210 | 1.53263694 |
| 26 | Legionellosis_Homo sapiens_hsa05134 | 1.42691832 |
| 27 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.39712345 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.36972077 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.33132935 |
| 30 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.32465315 |
| 31 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.31148019 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.29507818 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.29189788 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.28399243 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27547261 |
| 36 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.23582118 |
| 37 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.21173048 |
| 38 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.20724958 |
| 39 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.19239385 |
| 40 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.15500764 |
| 41 | Salmonella infection_Homo sapiens_hsa05132 | 1.14313966 |
| 42 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.14257084 |
| 43 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.12011760 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.09753119 |
| 45 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.09577110 |
| 46 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.08947834 |
| 47 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.07316376 |
| 48 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.06857837 |
| 49 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.06398053 |
| 50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05225849 |
| 51 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.03308860 |
| 52 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.02081321 |
| 53 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.98758404 |
| 54 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.95014880 |
| 55 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.94880042 |
| 56 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.93841736 |
| 57 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.90524030 |
| 58 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.89855733 |
| 59 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.89364883 |
| 60 | Hepatitis C_Homo sapiens_hsa05160 | 0.87742181 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87017064 |
| 62 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.85434245 |
| 63 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83968120 |
| 64 | Amoebiasis_Homo sapiens_hsa05146 | 0.83379242 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.82310687 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.80457822 |
| 67 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78707635 |
| 68 | Platelet activation_Homo sapiens_hsa04611 | 0.76982760 |
| 69 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.75156033 |
| 70 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.73005789 |
| 71 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.72226984 |
| 72 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.71708848 |
| 73 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.71578010 |
| 74 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.71062084 |
| 75 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.66600146 |
| 76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.64688064 |
| 77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64378383 |
| 78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61572104 |
| 79 | Asthma_Homo sapiens_hsa05310 | 0.60105065 |
| 80 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.59993326 |
| 81 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.59405454 |
| 82 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.58822853 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58135771 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57349716 |
| 85 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57075229 |
| 86 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57017499 |
| 87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56406636 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.54692382 |
| 89 | Allograft rejection_Homo sapiens_hsa05330 | 0.54323677 |
| 90 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54215765 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54145212 |
| 92 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.51538492 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50921938 |
| 94 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.50578108 |
| 95 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50534036 |
| 96 | Phototransduction_Homo sapiens_hsa04744 | 0.50120488 |
| 97 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.49509017 |
| 98 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.49471645 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48418407 |
| 100 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.48271553 |
| 101 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47700656 |
| 102 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45474103 |
| 103 | Insulin resistance_Homo sapiens_hsa04931 | 0.45151343 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.43439534 |
| 105 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42998631 |
| 106 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41930449 |
| 107 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41064368 |
| 108 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.40933292 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.40252063 |
| 110 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.39998919 |
| 111 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.39890389 |
| 112 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.39785645 |
| 113 | Histidine metabolism_Homo sapiens_hsa00340 | 0.37052486 |
| 114 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.36946622 |
| 115 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.36766330 |
| 116 | Olfactory transduction_Homo sapiens_hsa04740 | 0.36675417 |
| 117 | Long-term depression_Homo sapiens_hsa04730 | 0.36405792 |
| 118 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.36168726 |
| 119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33866174 |
| 120 | Morphine addiction_Homo sapiens_hsa05032 | 0.32506563 |
| 121 | Focal adhesion_Homo sapiens_hsa04510 | 0.32359392 |
| 122 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.31443051 |
| 123 | ABC transporters_Homo sapiens_hsa02010 | 0.31345725 |
| 124 | Prion diseases_Homo sapiens_hsa05020 | 0.31004618 |
| 125 | Colorectal cancer_Homo sapiens_hsa05210 | 0.30688498 |
| 126 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.30465671 |
| 127 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29658268 |
| 128 | Mineral absorption_Homo sapiens_hsa04978 | 0.28164992 |
| 129 | HTLV-I infection_Homo sapiens_hsa05166 | 0.27578308 |
| 130 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.26736971 |
| 131 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26371750 |
| 132 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.26189528 |
| 133 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.25606676 |

